Acurian completes enrollment contribution of more than 600 diabetes individuals for global.

Acurian completes enrollment contribution of more than 600 diabetes individuals for global, 9-protocol study Acurian, Inc., a respected, full-service provider of patient retention and recruitment solutions, announced today at the individual Recruitment & Retention for Diabetes & Obesity Studies Meeting in Amsterdam that it recently completed its enrollment contribution of over 600 diabetes individuals for a worldwide, nine-protocol diabetes study dapoxetine 30 mg side effects .

Naval Health Research Middle for evaluating triple mixture antiviral drug Adamas Pharmaceuticals, Inc., a privately held company, announced today that it offers entered into a Cooperative Analysis and Development Contract with america Naval Health Research Center for preclinical research evaluating Adamas’ triple combination antiviral medication therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas’ investigational proprietary fixed-dose oral combination drug, to be administered with a neuraminidase inhibitor adjunctively, including Tamiflu . Beneath the CRADA, the U.S. Naval Health Research Middle will conduct comparative checks of Adamas’ TCAD therapy against several strains of the influenza A virus, including seasonal influenza , avian influenza and novel influenza A/H1N1.